Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy.

Journal of medicine and life·2019
Same author

Tuberculosis, Crohn's disease and villous papilloma of the rectum.

Proceedings of the Royal Society of Medicine·2010
Same author

Correlation of Radiological and Histological Findings in Idiopathic Steatorrhoea.

British medical journal·2010
Same author

Sulphonamide investigations; the absorption and excretion in dairy cows of sulphapyridine, sulphamexathine, sulphamerazine, sulphadiazine, sulphathiazole and sulphapyrazine.

The Veterinary record·2010
Same author

Sulphonamide investigations; treatment of experimental Pasteurella septica, Ery. rhusiopathiae and S. cholerae-suis infections in mice with sulphathiazole, sulphadiazine, sulphamezathine and sulphapyridine.

The Journal of comparative pathology and therapeutics·2010
Same author

Sulphonamide investigations; the activity in vitro of sulphathiazole, sulphadiazine, sulphamerazine, sulphapyridine, sulphamezathine and sulphanilamide on some common animal pathogens.

The Journal of comparative pathology and therapeutics·2010

関連する実験動画

Updated: May 23, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

セリアック病と悪性腫瘍

C M Swinson, G Slavin, E C Coles

    Lancet (London, England)
    |January 15, 1983
    PubMed
    まとめ

    セリアック病の患者は,がん,特にリンパ腫および小腸腺がんを発症するリスクが高くなります. この研究は,セリアック病の個体における癌のリスクの増加を強調しています.

    科学分野:

    • 胃腸内科 胃腸内科
    • 腫瘍学 腫瘍学
    • エピデミオロジー エピデミオロジー

    背景:

    • セリアック疾患 (CD) は,グルテン摂取によって引き起こされる自己免疫疾患です.
    • CDの個人は,特定の癌,特に胃腸リンパ腫のリスクが高まっていることが知られている.

    研究 の 目的:

    • セリアック病と診断された患者の悪性腫瘍のスペクトルと発生率を調査する.
    • セリアック病患者のがんリスクを一般の人々と比較する.

    主な方法:

    • ヒストロジカルで確認されたセリアック病の患者235人の遡及的分析.
    • これらの患者で診断された259の組織学的に確認された悪性腫瘍のレビュー.
    • 観察されたがん発生率と,年齢と性別に調整された全国がん登録データとの比較.

    主要な成果:

    • 133の悪性腫瘍は悪性リンパ腫で,悪性ヒスティオシトーシスが主たるタイプであり,主に小腸に影響する.
    • 小腸アデノカルシノーマのリスクが有意に増加した (19例 vs. 0.23が予想される) ことが観察されました.
    • また,食道および喉の状細胞癌の発生率が高いことも指摘された.

    結論:

    さらに関連する動画

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
    06:24

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

    Published on: April 11, 2025

    関連する実験動画

    Last Updated: May 23, 2026

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
    10:27

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

    Published on: December 15, 2011

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
    06:24

    Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

    Published on: April 11, 2025

    • セリアック病は,リンパ腫やアデノカルシノーマを含む悪性腫瘍を発症するリスクが著しく高まっている.
    • 小腸は,セリアック病患者のこれらの悪性腫瘍の一般的な部位です.
    • 癌のリスクに関するセリアック病患者のさらなる研究と監視は正当化されています.